Drugs that contain Sevoflurane
1. Ultane patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5990176 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
| US6444859 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
| US6288127 | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jan, 2017
(7 years ago) | |
|
US6444859 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
|
US6288127 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
|
US5990176 (Pediatric) | ABBVIE | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
Jul, 2017
(6 years ago) | |
| US6074668 | ABBVIE | Container for an inhalation anesthetic |
Jan, 2018
(6 years ago) | |
|
US6074668 (Pediatric) | ABBVIE | Container for an inhalation anesthetic |
Jul, 2018
(5 years ago) | |
Market Authorisation Date: 07 June, 1995
Treatment: NA
Dosage: LIQUID;INHALATION
How can I launch a generic of ULTANE before it's drug patent expiration?
More Information on Dosage
ULTANE family patents
